ImportRefusal LogoImportRefusal

Novocol Pharmaceutical of Canada, Inc.

⚠️ Moderate Risk

FEI: 3002807757 • Cambridge, Ontario • CANADA

FEI

FEI Number

3002807757

📍

Location

Cambridge, Ontario

🇨🇦

Country

CANADA
🏢

Address

25 Wolseley Crt, , Cambridge, Ontario, Canada

Moderate Risk

FDA Import Risk Assessment

33.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
3
Unique Violations
7/26/2013
Latest Refusal
3/31/2009
Earliest Refusal

Score Breakdown

Violation Severity
58.9×40%
Refusal Volume
28.8×30%
Recency
0.0×20%
Frequency
11.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

37412×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.

Refusal History

DateProductViolationsDivision
7/26/2013
60QBY99ANESTHETIC, N.E.C.
118NOT LISTED
New York District Office (NYK-DO)
7/26/2013
60QDY67LIDOCAINE (ANESTHETIC)
118NOT LISTED
New York District Office (NYK-DO)
3/11/2013
60LBJ99ANALGESIC, N.E.C.
118NOT LISTED
3741FRNMFGREG
75UNAPPROVED
Florida District Office (FLA-DO)
3/11/2013
60LBJ99ANALGESIC, N.E.C.
118NOT LISTED
3741FRNMFGREG
75UNAPPROVED
Florida District Office (FLA-DO)
3/31/2009
60QCK07LIDOCAINE
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Novocol Pharmaceutical of Canada, Inc.'s FDA import refusal history?

Novocol Pharmaceutical of Canada, Inc. (FEI: 3002807757) has 5 FDA import refusal record(s) in our database, spanning from 3/31/2009 to 7/26/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Novocol Pharmaceutical of Canada, Inc.'s FEI number is 3002807757.

What types of violations has Novocol Pharmaceutical of Canada, Inc. received?

Novocol Pharmaceutical of Canada, Inc. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Novocol Pharmaceutical of Canada, Inc. come from?

All FDA import refusal data for Novocol Pharmaceutical of Canada, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.